There are 2789 resources available
LBA8 - Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
Presenter: Sjoukje Oosting
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast
LBA9 - IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC
Presenter: Enriqueta Felip
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast
Invited Discussant 567O_PR
Presenter: Rocio Garcia-Carbonero
Session: Presidential symposium 3
Resources:
Slides
Webcast
Invited Discussant 1557O and LBA8
Presenter: Marie von Lilienfeld-Toal
Session: Presidential symposium 3
Resources:
Slides
Webcast
Invited Discussant LBA9
Presenter: Benjamin Besse
Session: Presidential symposium 3
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Paolo G. Casali
Session: Rare cancers
Resources:
Slides
Webcast
Rare cancers: The main challenges, the recommendations, and the collaboration with the patient groups
Presenter: Paolo G. Casali
Session: Rare cancers
Resources:
Slides
Webcast
The European Refence Networks and the rare cancers
Presenter: Jean-Yves Blay
Session: Rare cancers
Resources:
Slides
Webcast
How the integration of specific national rare cancers plans into national cancer control plans can support the patients’ journey from diagnosis to treatment
Presenter: Ariane Weinman
Session: Rare cancers
Resources:
Slides
Webcast
Implementing clinical practice guidelines for rare cancers – mission accomplished?
Presenter: Kathy Oliver
Session: Rare cancers
Resources:
Slides
Webcast